That is what I am hoping for.
Google Finance CRME got changed to ESTIMATED March 10
Nothing new on their website either.
Like to see this go up like 4-5 years ago.
Intermune intm, or Intercept Phama icpt have shot up like a rocket, go CRME
Maybe we get into the $12's on Monday. One of the other AFib drugs on the market,
Xarelto by JNJ is featured in new lawyer ads. Causes excessive bleeding in
some stroke victims. We'll see.
look at 5 and ten year charts, then spent years in the $40's
They are taking advantage of higher stock price to issue more paper (money).
They have a decent balance sheet, but to prepare for a larger market (usa),
they will need more cash. The other AFib drugs on the market are showing
up in Lawsuit ads, hopefully we get an FDA Approval here, soon.
The up and down this week, 10 % + or - is due to options expiration, tomorrow.
Most are losing out.
Got to save some "up" for March 3 and 10.
I have been long since CRME was .88, March 2012.
This is going to pay off handsomely.